» Articles » PMID: 32796656

Characterizing Epitope Binding Regions of Entire Antibody Panels by Combining Experimental and Computational Analysis of Antibody: Antigen Binding Competition

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2020 Aug 16
PMID 32796656
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Vaccines and immunotherapies depend on the ability of antibodies to sensitively and specifically recognize particular antigens and specific epitopes on those antigens. As such, detailed characterization of antibody-antigen binding provides important information to guide development. Due to the time and expense required, high-resolution structural characterization techniques are typically used sparingly and late in a development process. Here, we show that antibody-antigen binding can be characterized early in a process for whole panels of antibodies by combining experimental and computational analyses of competition between monoclonal antibodies for binding to an antigen. Experimental "epitope binning" of monoclonal antibodies uses high-throughput surface plasmon resonance to reveal which antibodies compete, while a new complementary computational analysis that we call "dock binning" evaluates antibody-antigen docking models to identify why and where they might compete, in terms of possible binding sites on the antigen. Experimental and computational characterization of the identified antigenic hotspots then enables the refinement of the competitors and their associated epitope binding regions on the antigen. While not performed at atomic resolution, this approach allows for the group-level identification of functionally related monoclonal antibodies (i.e., communities) and identification of their general binding regions on the antigen. By leveraging extensive epitope characterization data that can be readily generated both experimentally and computationally, researchers can gain broad insights into the basis for antibody-antigen recognition in wide-ranging vaccine and immunotherapy discovery and development programs.

Citing Articles

Recent Progress in Antibody Epitope Prediction.

Zeng X, Bai G, Sun C, Ma B Antibodies (Basel). 2023; 12(3).

PMID: 37606436 PMC: 10443277. DOI: 10.3390/antib12030052.


State of the art in epitope mapping and opportunities in COVID-19.

Hamed S, Sakr M, El-Housseiny G, Wasfi R, Aboshanab K Future Sci OA. 2023; 16(3-06):FSO832.

PMID: 36897962 PMC: 9987558. DOI: 10.2144/fsoa-2022-0048.


Structure-free antibody paratope similarity prediction for epitope binning via protein language models.

Ghanbarpour A, Jiang M, Foster D, Chai Q iScience. 2023; 26(2):106036.

PMID: 36824280 PMC: 9941125. DOI: 10.1016/j.isci.2023.106036.


Computational epitope binning reveals functional equivalence of sequence-divergent paratopes.

Mahita J, Kim D, Son S, Choi Y, Kim H, Bailey-Kellogg C Comput Struct Biotechnol J. 2022; 20:2169-2180.

PMID: 35615020 PMC: 9118127. DOI: 10.1016/j.csbj.2022.04.036.


Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics.

Tutone M, Almerico A Molecules. 2021; 26(24).

PMID: 34946582 PMC: 8707150. DOI: 10.3390/molecules26247500.

References
1.
Sela-Culang I, Ofran Y, Peters B . Antibody specific epitope prediction-emergence of a new paradigm. Curr Opin Virol. 2015; 11:98-102. PMC: 4456244. DOI: 10.1016/j.coviro.2015.03.012. View

2.
Dimitrov D . Therapeutic antibodies, vaccines and antibodyomes. MAbs. 2010; 2(3):347-56. PMC: 2881260. DOI: 10.4161/mabs.2.3.11779. View

3.
van Kooij A, Middel J, Jakab F, Elfferich P, Koedijk D, Feijlbrief M . High level expression and secretion of truncated forms of herpes simplex virus type 1 and type 2 glycoprotein D by the methylotrophic yeast Pichia pastoris. Protein Expr Purif. 2002; 25(3):400-8. DOI: 10.1016/s1046-5928(02)00034-7. View

4.
Abbott W, Damschroder M, Lowe D . Current approaches to fine mapping of antigen-antibody interactions. Immunology. 2014; 142(4):526-35. PMC: 4107663. DOI: 10.1111/imm.12284. View

5.
Abdiche Y, Harriman R, Deng X, Yeung Y, Miles A, Morishige W . Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms. MAbs. 2015; 8(2):264-77. PMC: 4966639. DOI: 10.1080/19420862.2015.1118596. View